Idera Pharmaceuticals, Inc. (IDRA): Price and Financial Metrics

Idera Pharmaceuticals, Inc. (IDRA)

Today's Latest Price: $5.08 USD

0.10 (-1.93%)

Updated Dec 3 12:29pm

Add IDRA to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 389 in Biotech

See all "A" rated Strong Buy stocks

IDRA Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for IDRA is -10.06 -- better than only 1.79% of US stocks.
  • IDRA's price/sales ratio is 43.02; that's higher than the P/S ratio of 95.46% of US stocks.
  • As for revenue growth, note that IDRA's revenue has grown 255.77% over the past 12 months; that beats the revenue growth of 97.36% of US companies in our set.
  • Stocks that are quantitatively similar to IDRA, based on their financial statements, market capitalization, and price volatility, are SURF, NXTC, MVIS, CRUS, and MCRB.
  • IDRA's SEC filings can be seen here. And to visit Idera Pharmaceuticals Inc's official web site, go to

IDRA Stock Price Chart Interactive Chart >

Price chart for IDRA

IDRA Price/Volume Stats

Current price $5.08 52-week high $5.37
Prev. close $5.18 52-week low $0.81
Day low $4.95 Volume 548,569
Day high $5.37 Avg. volume 277,109
50-day MA $2.88 Dividend yield N/A
200-day MA $2.10 Market Cap 179.08M

Idera Pharmaceuticals, Inc. (IDRA) Company Bio

Idera Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of novel therapeutics for oncology and rare diseases in the United States. The company was founded in 1989 and is based in Cambridge, Massachusetts.

IDRA Latest News Stream

Event/Time News Detail
Loading, please wait...

IDRA Latest Social Stream

Loading social stream, please wait...

View Full IDRA Social Stream

Latest IDRA News From Around the Web

Below are the latest news stories about Idera Pharmaceuticals Inc that investors may wish to consider to help them evaluate IDRA as an investment opportunity.

Idera announces patent coverage for tilsotolimod through September 2037

Idera Pharmaceuticals (IDRA) receives patent and is allowed application entitled 'Immune Modulation with TLR9 Agonists for Cancer Treatment' for investigational therapy tilsotolimod.The patents and the allowed application provide exclusivity for certain uses of tilsotolimod through September 2037.“The CRC patent and the soon-to-issue HNSCC patent fortify our ‘beyond melanoma’ strategy for tilsotolimod, which...

Seeking Alpha | September 28, 2020

Idera Pharmaceuticals (IDRA) Investor Presentation - Slideshow

The following slide deck was published by Idera Pharmaceuticals, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | August 13, 2020

Idera Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update

Enhanced Financial Flexibility as ILLUMINATE-301 Continues on Track

GlobeNewswire | August 4, 2020

Idera Pharmaceuticals Announces Private Placement of up to $20.0 Million

EXTON, Pa., July 15, 2020 -- Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today announced entering into an agreement with a fund affiliated with institutional investors providing.

Yahoo | July 15, 2020

Idera Pharmaceuticals Inc (IDRA): Hedge Funds Are Nibbling On

In this article we will check out the progression of hedge fund sentiment towards Idera Pharmaceuticals Inc (NASDAQ:IDRA) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research

Yahoo Finance | June 21, 2020

Read More 'IDRA' Stories Here

IDRA Price Returns

1-mo 69.33%
3-mo 159.18%
6-mo 160.51%
1-year 180.66%
3-year -70.19%
5-year -83.29%
YTD 179.12%
2019 -34.30%
2018 -83.59%
2017 40.67%
2016 -51.46%
2015 -29.93%

Continue Researching IDRA

Want to see what other sources are saying about Idera Pharmaceuticals Inc's financials and stock price? Try the links below:

Idera Pharmaceuticals Inc (IDRA) Stock Price | Nasdaq
Idera Pharmaceuticals Inc (IDRA) Stock Quote, History and News - Yahoo Finance
Idera Pharmaceuticals Inc (IDRA) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8126 seconds.